The Centre for Biologic Therapies (CBT), a collaboration between WEHI and CSL, is dedicated to advancing early-phase biologics discovery and the development of antibody-based therapeutics to treat human diseases. The Centre employs state-of-the-art antibody discovery platforms, and advanced antibody engineering and optimisation technologies to achieve its mission.
Our team of research scientists, from diverse disciplines, brings a broad range of expertise to drive our work forward. Our mission is to accelerate basic research and discoveries into impactful, life-changing treatments for patients by harnessing cutting-edge science, advanced technologies, and fostering strong collaborations with researchers, clinicians, and industry experts.
